Thursday, 08. January 2009

Startpage > All projects > FP6 Life Science Health > Advanced genomics and its applications for health > Application of knowledge and technologies > Rational and accelerated development of new, safer, more effective drugs


		All projects


		FP6 Life Science Health


		Advanced genomics and its applications for health


		Fundamental knowledge and basic tools for functional genomics


		Application of knowledge and technologies


		Rational and accelerated development of new, safer, more effective drugs


		Screening for drug candidates targeting aberrant molecular signalling


		Microdosing' studies to gain enhanced absorption, distribution, metabolism, excretion (ADME)


		Targeted delivery of protein-based drugs (especially orientated towards involvement of SMEs)


		Development of new diagnostics


		Development and testing of new preventive and therapeutic tools


		Combating major diseases


		Specific support actions across thematic priority 1


		FP6 Information society technologies


		FP6 Others


		FP5 Life Quality


		About the region


		Thematic areas


		IFR


		About European projects

ACIES SAS (FR716 - Rhône) (France) (»add to infobox)

Region	FR716 - Rhône
Country	France
Internet	http://www.acies.fr
Type	Company

PERSONS (8/8)

Maud SEGUY (Contact / ACIES SAS (FR716 - Rhône) (France))

Laurence LAPÔTRE (Contact / ACIES SAS (FR716 - Rhône) (France))

Gerald GROSSIN (Contact / ACIES SAS (FR716 - Rhône) (France))

Sandrine RIVAL (Contact / ACIES SAS (FR716 - Rhône) (France))

Bénédicte CHARRIN (Contact / ACIES SAS (FR716 - Rhône) (France))

Constantin SKARVELAKIS (Contact / ACIES SAS (FR716 - Rhône) (France))

Jean-Luc ROUX (Contact / ACIES SAS (FR716 - Rhône) (France))

N. N. (Contact / ACIES SAS (FR716 - Rhône) (France))

RELATED NAVIGATION AREA(S) (11/11)

Cancerology

Characterisation and use of animal models for neurological and psychiatric diseases

FP6 Information society technologies

Infectiology

Innovative diagnostic approaches and novel therapies of childhood cancers

Microdosing' studies to gain enhanced absorption, distribution, metabolism, excretion (ADME)

Neurosciences

Oncolytic virus vectors for cancer virotherapy (especially orientated towards involvement of SMEs)

Rare inherited neuromuscular disorders: from molecular basis to cutting edge therapies

Research in poverty-related diseases by SMEs

Use of baculovirus as a vector in gene therapy (especially orientated towards small and medium sized companies)

RELATED PROJECTS (10/10)

READ-UP - REdox Antimalarial Drug discovery (FP6-LIFESCIHEALTH)

BACULOGENES - Baculovirus vectors for gene therapy (FP6-LIFESCIHEALTH)

CHILDHOPE - Chimaeric T-cells for the treatment of paediatric cancers (FP6-LIFESCIHEALTH)

MEMORIES - Development, characterisation and validation of new and original models for Alzheimer's Disease' (FP6-LIFESCIHEALTH)

EUMAPP - European Union Microdose AMS Partnership Programme (FP6-LIFESCIHEALTH)

THERADPOX - Optimised and novel oncolytic adenoviruses and pox viruses in the treatment of cancer: Virotherapy combined with molecular chemotherapy (FP6-LIFESCIHEALTH)

NANOCMOS - "CMOS backbone for 2010 e-Europe "NANOCMOS" From the 45 nm node down to the limits" (FP6-IST)

TREAT-NMD - Translational Research in Europe - Assessment and Treatment of Neuromuscular Diseases (FP6-LIFESCIHEALTH)

PULLNANO - PULLing the limits of NANOCmos electronics (FP6-IST)

AETHER - self-Adaptive Embedded Technologies for Pervasive Computing Architectures (FP6-IST)

Advanced Search

OVERVIEWS

Sitemap

Organisation List

Person List

INFOBOX (0/0)

show all


Your infobox is empty